BioCentury
ARTICLE | Financial News

Mesoblast completes follow-on

November 16, 2015 8:00 AM UTC

Mesoblast Ltd. (ASX:MSB; NASDAQ:MESO), Melbourne, Australia Business: Gene/Cell therapy Date completed: 2015-11-13 Type: Follow-on Raised: $59.8 million Shares: 7.5 million Price: $8 Shares after offe...